EUClinicalTrials.govClinical trialNot applicableRecruiting
Integrating Artificial Intelligence Into Lung Cancer Screening.
Official record
- Identifier
NCT05704920- Recruiting locations
country
France- Interventions studied
- IANot IA
- Lead sponsor
- Centre Hospitalier Universitaire de Nice
- Target enrolment
- 2722 participants
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Status
- Recruiting
- First posted
- Jan 30, 2023
- Last updated on the registry
- Oct 1, 2026
- Age
- 18 Years – 80 Years
- Sex
- ALL
- Study contact
- The official record lists a study contact. Contact details are published there and are intentionally not copied to this page.
- Eligibility criteria
Reproduced verbatim from the official record. Eligibility is decided by the study team, never by this page.
Inclusion Criteria: * Age between 50 and 80 years old * active smoker or ex-smoker who quit smoking less than 15 years ago * smoking history of at least 20 pack-years * signature of the informed consent * affiliation to French social security Exclusion Criteria: * clinical signs suggestive of cancer * recent chest scan (\<1 year) for another cause * radiological abnormality requiring follow-up or additional investigations * health problem significantly limiting life expectancy from the clinician's point of view * health problem limiting ability or willingness to undergo lung surgery * Patients with active neoplasia, except basal cell carcinoma of the skin. * vulnerable people: adults under guardianship, adults under curatorship medical and/or psychiatric problems of sufficient severity to limit full adherence to the study or expose patients to excessive risk
- Indexed under
- Lung Cancer